© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Cefuroxime Sodium stands out as a second-generation cephalosporin antibiotic. It targets a broad range of infections caused by bacteria. Developed for intravenous and intramuscular use, it keeps its spot in many hospital supply rooms. The chemical structure lets it disrupt bacterial cell wall synthesis, weakening invaders and supporting recovery in stubborn infections that resist penicillins. Medical teams reach for this compound due to the way it tackles tough respiratory tract infections, urinary tract infections, skin issues, meningitis, and post-surgical threats. Healthcare communities across the globe value the reliability this substance brings to patient care.
Bulk packaging of Cefuroxime Sodium appears in forms like powder or crystalline flakes. These solid forms handle storage and reconstitution for clinical use. The substance draws attention for its stability, often stored in sealed vials to block light and moisture. Laboratories see this compound handled in root raw form, letting controlled dilution with sterile water or saline happen just before administration. The color ranges from almost white to pale yellow. The texture signals its purity, and too sticky or granular samples flag poor storage or contamination. Manufacturers put a lot of emphasis on reaching strict density and consistency standards. Any fluctuation hints at possible degradation.
Cefuroxime Sodium's molecular formula is C16H15N4NaO8S. With a molar mass close to 446.36 g/mol, the compound draws attention from chemists due to its β-lactam ring fused with a dihydrothiazine ring. This particular structure grants it resistance against certain beta-lactamases, enzymes bacteria use to fight off common antibiotics. The sodium salt form builds on its water solubility—critical for injection and solution stability. In the lab, dissolution profiles matter. The property lets medical staff deliver steady, predictable dosages. The compound’s melting point varies across sources, but it normally sits around 155-160°C, enough to maintain shelf life in non-refrigerated storage.
As a raw powder, Cefuroxime Sodium sits at about 1.6 g/cm³ density. Handling the neat product calls for care: the powder releases a faint odor, and it clumps slightly in humid air. Manufacturers choose the sodium form precisely because it's less hygroscopic compared to other cephalosporin salts. In terms of specific forms, users encounter granules, fine powders, and, on rare occasions, compressed pearls for easier reconstitution. The crystal size impacts both solubility and injection smoothness. This matters during high-volume hospital use, where nurses need a fast-dissolving, lump-free powder. Shelf-stable exposure requires an airtight, light-impermeable package. Out in solution, Cefuroxime Sodium exhibits near-complete transparency, confirming proper dilution and compatibility with standard infusion fluids.
The Harmonized System (HS) Code for Cefuroxime Sodium typically falls under 29419090, listed as an antibiotic under semi-synthetic cephalosporins. Customs authorities and pharmaceutical importers track this for global shipments, ensuring tax compliance and safety monitoring. Advocacy around supply chain transparency highlights the importance of precise HS coding, which deters counterfeit imports and promotes genuine sourcing from licensed suppliers.
Pure Cefuroxime Sodium holds value but demands respect for safety guidelines. Direct skin contact can spark rashes or irritation, especially for sensitive individuals. Laboratory staff often wear gloves and goggles to block accidental splashes. Airborne particles rarely escape tightly sealed containers, but accidental inhalation can aggravate asthma or breathing problems. Spills rarely warrant extreme action, though quick cleanup with moist towels prevents accidental skin exposure. Waste disposal routes follow hazardous pharmaceutical standards—never poured down drains without neutralization. Inhalation, ingestion, or injection in non-medical settings risks allergic responses ranging from mild itchiness to severe anaphylaxis. For staff, having access to material safety data and clear labeling avoids accidental misuse and protects vulnerable patients.
Pharmaceutical companies rely on bulk Cefuroxime Sodium as a critical raw input for sterile injectable drugs. Strict traceability starts from source production all the way through to the finished vial. Quality checks typically include infrared spectroscopy, high-performance liquid chromatography (HPLC), and sterility tests after compounding. Laboratories store the raw batch in controlled environments—cool, dry, with tight temperature ranges—since spoilage directly impacts downstream patient safety. Trends in global demand place pressure on supply chains, and shortages highlight the risks of relying on too few trusted sources. Manufacturers investing in vertical integration protect themselves, but collaboration with suppliers for better transparency, documentation, and early warning systems helps stabilize the raw material market.
